00000nam 2200000zi 4500 9.919143 CaOODSP 20250218135237 m o d f cr cn||||||||| 230113t20222022onc ob f000 0 eng d 9780660470818 CaOODSP eng rda CaOODSP n-cn--- Iu37-37/2023E-PDF Post-COVID-19 condition in Canada : what we know, what we don't know, and a framework for action. Ottawa, ON : Innovation, Science and Economic Development Canada = Innovation, sciences et développement économique Canada, December 2022. ©2022 1 online resource (51 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in French under title: Le syndrome post-COVID-19 au Canada : état des connaissances et cadre d'action. Includes bibliographical references. "The COVID pandemic has had devastating effects on our society and on human health and mortality. Over the past two years, evidence has emerged to suggest that the impacts of COVID-19 extend beyond the acute phase of the disease which, in some infected individuals, can turn into a chronic illness. In Canada, as of August 2022, more than 1.4 million people – or about 15 percent of adults who have contracted COVID-19 – say they experience symptoms three months or more after their initial SARS-CoV-2 virus infection. These include respiratory, cardiovascular, neurological and cognitive impairments and they can be debilitating"--Executive summary, page 2. COVID-19 (Disease) Diagnosis Canada. COVID-19 (Disease) Treatment Canada. COVID-19 Pandemic, 2020-2023 Health aspects Canada. Chronic diseases Canada. Canada. Innovation, Science and Economic Development Canada, issuing body. Le syndrome post-COVID-19 au Canada : (CaOODSP)9.919144 PDF 1.39 MB https://publications.gc.ca/collections/collection_2023/isde-ised/Iu37-37-2023-eng.pdf HTML N/A https://science.gc.ca/site/science/en/office-chief-science-advisor/initiatives-covid-19/post-covid-19-condition-canada-what-we-know-what-we-dont-know-and-framework-action-pre-report